Questionable treatments for children with autism
The Chicago Tribune examined four treatments in depth for this series. Medical experts said the therapies have not been proven to help children with autism and that each also carries risks.
The Record and Herald News,
Tue Nov 24 14:04:05 PST 2009
• Found on Yahoo! News
Chemotherapy with cetuximab yields high response rates compared with historical co...
Neoadjuvant chemotherapy for unresectable colorectal liver metastases can downsize tumours for curative resection. We assessed the effectiveness of cetuximab combined with chemotherapy in t...
Lancet,
Tue Nov 24 16:21:37 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Genasense(R) Given As High-Dose IV Infusion With Chemotherapy Shows Promising Acti...
Genta Incorporated (OTCBB: GETA.OB) announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company'...
Medical News Today,
Mon Nov 23 07:36:48 PST 2009
• Found on Yahoo! News
Advanced Biliary-Tract Cancers: Promising New Drug Regimen
An article published Online First in The Lancet Oncology reports that bevacizumab given in addition to the combined chemotherapy regimen of gemcitabine and oxaliplatin (GEMOX-B) is well tol...
Medical News Today,
Mon Nov 23 03:39:37 PST 2009
• Found on Yahoo! News
18
Previous phase 2 studies have shown antitumour activity with gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary-tract cancers (BTCs).
Lancet,
Mon Nov 23 02:06:36 PST 2009
• Found on Yahoo! News
Insmed Incorporated - Pharmaceuticals & Healthcare - Deals And Alliances Profile -...
Insmed Incorporated (Insmed) is a biopharmaceutical company engaged in developing recombinant protein drug. The Company is developing products for anemia, neutropenia, and autoimmune diseas...
OfficialWire,
Thu Nov 19 08:56:54 PST 2009
• Found on Yahoo! News
OncQuest launches UGT1 A1 genotyping for predicting therapeutic response of Irinot...
OncQuest Laboratories Ltd, the pioneer in the Indian Oncology clinical testing, has launched UGT1A1 Genotyping for determining therapeutic response of Irinotecan, a chemotherapy drug which ...
PharmaBiz,
Fri Nov 20 18:51:55 PST 2009
• Found on Yahoo! News
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatme...
PRINCETON, N.J. & TOKYO----Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has approved the supplemental New Drug...
Business Wire via Yahoo! Finance,
Fri Nov 20 15:50:00 PST 2009
• Found on Yahoo! News
NeoPharm Presents The Phase I Data For Patients With Metastatic Solid Tumors
NeoPharm, Inc. (Other OTC: NEOL.PK) announced the results of a Phase I clinical trial of Liposome Encapsulated Docetaxel (LE-DT) an active component of Taxotere® at a joint International Co...
Medical News Today,
Thu Nov 19 04:38:37 PST 2009
• Found on Yahoo! News
Enzon Presents Data at 2009 EORTC Meeting
BRIDGEWATER, N.J.----Enzon Pharmaceuticals, Inc. presented data from its pipeline programs at the 2009 EORTC-NCI-AACR annual meeting in Boston, Massachusetts.
Business Wire via Yahoo! Finance,
Thu Nov 19 06:19:00 PST 2009
• Found on Yahoo! News
/C O R R E C T I O N -- Teva UK Ltd/
LEEDS, England, November 18 /PRNewswire/ -- In the news release, "Teva Launches TevaGrastim(R) (filgrastim)" issued on 18 Nov 2009 07:00 GMT, by Teva UK Ltd over PR Newswire, due to an omis...
ITNews,
Wed Nov 18 11:43:18 PST 2009
• Found on Yahoo! News
/C O R R E C T I O N -- Teva UK Ltd/
In the news release, "Teva Launches TevaGrastim® " issued on
PR Newswire via Yahoo! Finance,
Wed Nov 18 11:39:00 PST 2009
• Found on Yahoo! News
Teva Launches TevaGrastim(R) (filgrastim)
LEEDS, England, November 18 /PRNewswire/ -- Teva UK Limited has signalled its commitment to developing biosimilar medicines by entering the G-CSF* therapy area.
ITNews,
Tue Nov 17 23:13:58 PST 2009
• Found on Yahoo! News
Millennium Initiates First Clinical Trial with the First Oral Proteasome Inhibitor
CAMBRIDGE, Mass.----Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an or...
Business Wire via Yahoo! Finance,
Wed Nov 18 06:36:00 PST 2009
• Found on Yahoo! News
NeoPharm presents LE-DT Phase I data at the AACR conference
NeoPharm, Inc. today announced the results of a Phase I clinical trial of Liposome Encapsulated Docetaxel (LE-DT) an active component of Taxotere® at a joint International Conference of the...
News-Medical-Net,
Wed Nov 18 01:42:28 PST 2009
• Found on Yahoo! News
Threshold Pharmaceuticals Presents Interim Prostate Cancer Data From Early Stage T...
REDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were pres...
GlobeNewswire via Yahoo! Finance,
Wed Nov 18 05:45:00 PST 2009
• Found on Yahoo! News
Teva Launches TevaGrastim(R) (filgrastim)
Teva UK Limited has signalled its commitment to developing biosimilar medicines by entering the G-CSF* therapy area. The launch of its proprietary version of filgrastim, TevaGrastim®, marks...
PR Newswire via Yahoo! Finance,
Tue Nov 17 23:00:00 PST 2009
• Found on Yahoo! News
Genta announces preliminary results from study of Genasense Injection for advanced...
Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company
News-Medical-Net,
Fri Nov 20 06:12:18 PST 2009
• Found on Yahoo! News